Dose-ranging effects of SGLT2 inhibitors in patients with type 2 diabetes: a systematic review and meta-analysis

被引：0
|
作者：
Pinto, L. C. [1 ]
Rados, D. R. [1 ]
Retnonti, L. R. [1 ]
Viana, M. V. [1 ]
Leitao, C. B. [1 ]
Gross, J. L. [1 ]
机构：
[1] Univ Fed Rio Grande do Sul, Endocrine Div, Porto Alegre, RS, Brazil
来源：
DIABETOLOGIA | 2018年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
645
引用
收藏
页码：S313 / S313
页数：1
相关论文
共 50 条
  • [31] Pharmacological selectivity of SGLT2 inhibitors and cardiovascular outcomes in patients with type 2 diabetes: a meta-analysis
    Sayour, A. A.
    Olah, A.
    Ruppert, M.
    Barta, B. A.
    Benke, K.
    Merkely, B.
    Radovits, T.
    EUROPEAN HEART JOURNAL, 2022, 43 : 2688 - 2688
  • [32] Effect of SGLT2 inhibitors on fractures, BMD, and bone metabolism markers in patients with type 2 diabetes mellitus: a systematic review and meta-analysis
    Wang, Xin
    Zhang, Fengyi
    Zhang, Yufeng
    Zhang, Jiayi
    Sheng, Yingli
    Wang, Wenbo
    Li, Yujie
    OSTEOPOROSIS INTERNATIONAL, 2023, 34 (12) : 2013 - 2025
  • [33] Association of SGLT2 Inhibitors With Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes A Meta-analysis
    McGuire, Darren K.
    Shih, Weichung J.
    Cosentino, Francesco
    Charbonnel, Bernard
    Cherney, David Z. I.
    Dagogo-Jack, Samuel
    Pratley, Richard
    Greenberg, Michelle
    Wang, Shuai
    Huyck, Susan
    Gantz, Ira
    Terra, Steven G.
    Masiukiewicz, Urszula
    Cannon, Christopher P.
    JAMA CARDIOLOGY, 2021, 6 (02) : 148 - 158
  • [34] The effect of SGLT2 inhibitors on kidney stones; a systematic review and meta-analysis
    Sisakht, Ali Rahnama
    Kamkar, Parvin
    Darzi, Mohammad Mehdi
    Madani, Mohammad Hamidi
    Arismani, Rasoul Jafari
    Gharebakhshi, Farshad
    Behi, Mahdi
    Mardanparvar, Hossein
    Haghighi, Ramin
    JOURNAL OF RENAL INJURY PREVENTION, 2024,
  • [35] The Role of SGLT2 Inhibitors in Heart Failure: A Systematic Review and Meta-Analysis
    Tsampasian, Vasiliki
    Baral, Ranu
    Chattopadhyay, Rahul
    Debski, Maciej
    Joshi, Shruti S.
    Reinhold, Johannes
    Dweck, Marc R.
    Garg, Pankaj
    Vassiliou, Vassilios S.
    CARDIOLOGY RESEARCH AND PRACTICE, 2021, 2021
  • [36] Effects and safety of SGLT2 inhibitors compared to placebo in patients with heart failure: A systematic review and meta-analysis
    Chambergo-Michilot, Diego
    Tauma-Arrue, Astrid
    Loli-Guevara, Silvana
    IJC HEART & VASCULATURE, 2021, 32
  • [37] Impact of SGLT2 Inhibitors on Mortality Risk in Type 2 Diabetes Mellitus and Coronary Artery Disease: A Systematic Review and Meta-Analysis
    Gonzales, Antony
    Collantes-Silva, Nicole
    Arambulo-Castillo, Sebastian
    Ortiz-Benique, Zhamanda N.
    Munoz-Moreno, Juan Manuel
    Alarcon, Esteban
    CIRCULATION, 2024, 150
  • [38] Safety and efficacy of sodium-glucose cotransporter 2 (SGLT2) inhibitors in type 1 diabetes: A systematic review and meta-analysis
    El Masri, Dana
    Ghosh, Samiran
    Jaber, Linda A.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2018, 137 : 83 - 92
  • [39] SGLT2 inhibitors in type 2 diabetes, a systematic review and meta-analysis of cardiovascular outcome trials balancing their benefits against their risks
    Marilly, E.
    Cottin, J.
    Cabrera, N.
    Cornu, C.
    Boussageon, R.
    Moulin, P.
    Lega, J. C.
    Gueyffier, F.
    Cucherat, M.
    Grenet, G.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2022, 36 : 168 - 168
  • [40] GLP-1 receptor agonists and SGLT2 inhibitors for older people with type 2 diabetes: A systematic review and meta-analysis
    Karagiannis, Thomas
    Tsapas, Apostolos
    Athanasiadou, Eleni
    Avgerinos, Ioannis
    Liakos, Aris
    Matthews, David R.
    Bekiari, Eleni
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2021, 174
12345